Literature DB >> 78928

Comparison of immunofluorescence and immunoperoxidase staining for identification of rubella virus isolates.

N J Schmidt, J Dennis, E H Lennette.   

Abstract

To explore possible advantages which immunoperoxidase (IP) staining might have over immunofluorescence (IF) staining for identifying rubella virus isolates, direct comparative studies were done on the same coded clinical materials using the same rubella immune rabbit serum as the primary antiserum in both systems. The rubella immune rabbit serum and conjugated anti-rabbit immune globulins could be used more dilute in the IP system than in the IF system. Both IP and IF staining detected rubella antigen in all specimens which were positive by interference. IP staining also detected low levels of rubella antigen in a few additional specimens which had originally been positive for rubella virus, but which on retesting were negative by interference and IF staining. With second-cell-culture-passage material, IP and IF staining showed comparable specificity, and the few specimens which reacted nonspecifically generally did so in both systems. Cell cultures inoculated directly with urine specimens showed greater nonspecificity by IP than by IF, but this activity could be abolished by pretreatment with sodium azide and peroxide; other methods tried for inactivating endogenous peroxidase activity destroyed rubella antigen as well. The intensity of staining for positive specimens was comparable in the two systems. However, more antigen was demonstrable in both systems when BHK-21 cells were inoculated as a cell suspension and then permitted to grow into monolayers than when the same specimens were inoculated into preformed monolayers. IP staining was considered to be a highly satisfactory alternative to IF staining for identification of rubella virus isolates.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78928      PMCID: PMC275075          DOI: 10.1128/jcm.7.6.576-583.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  CYTOCHEMICAL DEMONSTRATION OF PEROXIDASE ACTIVITY WITH 3-AMINO-9-ETHYLCARBAZOLE.

Authors:  R C GRAHAM; U LUNDHOLM; M J KARNOVSKY
Journal:  J Histochem Cytochem       Date:  1965-02       Impact factor: 2.479

2.  Improved mountant for immunofluorescence preparations.

Authors:  G V Heimer; C E Taylor
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

3.  Letter: Destruction of endogenous peroxidase activity in order to locate cellular antigens by peroxidase-labeled antibodies.

Authors:  A Pitts; E E Williams
Journal:  J Histochem Cytochem       Date:  1974-01       Impact factor: 2.479

4.  Identification of rubella virus isolates by immunofluorescent staining, and a comparison of the sensitivity of three cell culture systems for recovery of virus.

Authors:  N J Schmidt; E H Lennette; J D Woodie; H H Ho
Journal:  J Lab Clin Med       Date:  1966-09

5.  Inhibition of peroxidase by methanol and by methanol-nitroferricyanide for use in immunoperoxidase procedures.

Authors:  W Straus
Journal:  J Histochem Cytochem       Date:  1971-11       Impact factor: 2.479

6.  Physical and immunologic properties of rubella antigens.

Authors:  N J Schmidt; E H Lennette; P S Gee; J Dennis
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

7.  A modified indirect immunofluorescent staining technique for the demonstration of rubella antibodies in human sera.

Authors:  E H Lennette; J D Woodie; N J Schmidt
Journal:  J Lab Clin Med       Date:  1967-04

8.  Rubella virus identification in primary and continuous monkey kidney cell cultures by immunoperoxidase technique.

Authors:  G Gerna
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

9.  Letter: Substitute for benzidine in myeloperoxidase stains.

Authors:  I S Kaplow
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

10.  Rubella virus carrier cultures derived from congenitally infected infants.

Authors:  W E Rawls; J L Melnick
Journal:  J Exp Med       Date:  1966-05-01       Impact factor: 14.307

View more
  8 in total

1.  Comparative efficacy of fluorescent antibody test, immunoperoxidase test and enzyme linked immuno sorbent assay in detection of rotavirus in cell culture.

Authors:  N N Barman; A J Nath; B K Neog; G Das
Journal:  Virusdisease       Date:  2014-02-07

2.  Sensitivity and efficiency of four immunohistochemical methods as defined by staining of artificial sections.

Authors:  K Valnes; P Brandtzaeg; T O Rognum
Journal:  Histochemistry       Date:  1984

3.  Quantitation of immunoglobulin- and peptide hormone-producing cells in gastrointestinal mucosa. Comparison of direct immunofluorescence and the unlabelled antibody peroxidase--antiperoxidase method.

Authors:  K Valnes; P Brandtzaeg; L E Hanssen; R Stave; S Larsen; W Londong
Journal:  Histochem J       Date:  1983-10

4.  Application of immunoperoxidase staining to more rapid detection and identification of rubella virus isolates.

Authors:  N J Schmidt; H H Ho; J Chin
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

5.  Alpha interferon administration to infants with congenital rubella.

Authors:  A M Arvin; N J Schmidt; K Cantell; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Use of monoclonal antibodies to human immunoglobulin M in "capture" assays for measles and rubella immunoglobulin M.

Authors:  B Forghani; C K Myoraku; N J Schmidt
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates.

Authors:  N J Schmidt; M Ota; D Gallo; V L Fox
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

8.  Multiple-antigen slide test for detection of immunoglobulin M antibodies in newborn and infant sera by immunofluorescence.

Authors:  D Gallo; J L Riggs; J Schachter; R W Emmons
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.